InMed Pharmaceuticals Inc Sustainability Reports
InMed Pharmaceuticals Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of rare cannabinoids and small molecule drug candidates targeting CB1/CB2 receptors for diseases with high unmet medical needs.
Sector: Manufacturing
Country: Canada
Exchange: Nasdaq
LEI: 549300VA5DNHEJGHG397
4 reports from 2021 to 2025
Company Profile
InMed Pharmaceuticals Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of rare cannabinoids and small molecule drug candidates targeting CB1/CB2 receptors for diseases with high unmet medical needs.
Reports
4 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
